newsfilter
← Latest News
GlobeNewswire·

Neon Therapeutics Reports Third Quarter 2019 Financial Results and Recent Highlights

CAMBRIDGE, Mass., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today reported...